Paying users zone. Data is covered by .

  • Get to Celgene Corp. for $13.99, or

  • get to whole website for at least 3 months from $49.99.


Statement of Cash Flows Quarterly Data

Difficulty: Beginner

The cash flow statement provides information about a company's cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company's statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Celgene Corp., Consolidated Statement of Cash Flows (quarterly data)

USD $ in millions

3 months ended Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013
Net income (loss)
Impairment charges
Provision for accounts receivable allowances
Deferred income taxes
Change in value of contingent consideration and success payments
Gain on sale of business
Net (gain) loss on sales of debt securities available-for-sale
Net gain on equity investments with and without a readily determinable fair value
Share-based compensation expense
Share-based employee benefit plan expense
Derivative instruments
Realized losses on marketable securities available for sale
Other, net
Accounts receivable
Other operating assets
Accounts payable and other operating liabilities
Income tax payable
Payment of contingent consideration
Deferred revenue
Change in current assets and liabilities, excluding the effect of acquisitions and disposals
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Net cash provided by (used in) operating activities
Proceeds from sales of debt securities available-for-sale
Purchases of debt securities available-for-sale
Capital expenditures
Proceeds from sales of equity investment securities
Purchases of equity investment securities
Payments for acquisition of businesses, net of cash acquired
Net cash (used in) provided by investing activities
Payment for treasury shares
Proceeds from short-term borrowing
Principal repayments on short-term borrowing
Proceeds from issuance of long-term debt
Repayments of long-term debt
Net proceeds (payments) from common equity put options
Payment of contingent consideration
Net proceeds from share-based compensation arrangements
Excess tax benefit from share-based compensation arrangements
Net cash provided by (used in) financing activities
Effect of currency rate changes on cash and cash equivalents
Net increase (decrease) in cash and cash equivalents
Source: Celgene Corp., Quarterly and Annual Reports
Item Description The company
Net cash provided by (used in) operating activities The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities. Celgene Corp.'s net cash provided by (used in) operating activities increased from Q3 2017 to Q4 2017 but then declined significantly from Q4 2017 to Q1 2018.